StatPearls, LLC

  • Coitus
  • Contraception, Postcoital
  • Contraceptive Effectiveness
  • Contraceptives, Postcoital
  • Levonorgestrel

Levonorgestrel

Levonorgestrel, also known as the morning-after pill, is a first-line oral emergency contraceptive pill with approval from the World Health Organization to prevent pregnancy. It is FDA-approved to be used within 72 hours of unprotected sexual intercourse or when a presumed contraceptive failure has occurred. There have been cases of off-label efficacy for up to 96 hours. This activity covers levonorgestrel, including its mechanism of action, pharmacology, adverse event profiles, and monitoring and clinical toxicity. Grasping the complex pharmacology of levonorgestrel equips healthcare professionals to tailor contraceptive and therapeutic strategies to individual patient needs effectively. This continuing medical education (CME) activity is designed to provide essential knowledge and practical tools for the optimal use of levonorgestrel in various clinical contexts, including emergency contraception. This educational initiative underscores the critical role of the interprofessional healthcare team in prescribing, counseling, and monitoring patients on levonorgestrel therapy. The emphasis is on empowering healthcare professionals, emphasizing the essential role of the interprofessional healthcare team in managing levonorgestrel therapy. The CME program emphasizes the application of evidence-based medicine to enhance reproductive health outcomes and reduce unintended pregnancies. This training will equip healthcare professionals with the knowledge to ensure safe, effective, and patient-centered care when utilizing levonorgestrel-containing products across diverse populations and settings. Overall, this comprehensive CME program enables healthcare professionals to deliver targeted, safe, and personalized care, enhancing patient outcomes related to levonorgestrel therapy.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left